Multiplex Amplification Coupled with COLD-PCR and High Resolution Melting Enables Identification of Low-Abundance Mutations in Cancer Samples with Low.

Slides:



Advertisements
Similar presentations
Measurement of Relative Copy Number of CDKN2A/ARF and CDKN2B in Bladder Cancer by Real-Time Quantitative PCR and Multiplex Ligation-Dependent Probe Amplification.
Advertisements

Keyur P. Patel, Bedia A. Barkoh, Zhao Chen, Deqin Ma, Neelima Reddy, L
Reality of Single Circulating Tumor Cell Sequencing for Molecular Diagnostics in Pancreatic Cancer  Colin M. Court, Jacob S. Ankeny, Shonan Sho, Shuang.
Detection of Exon 12 Mutations in the JAK2 Gene
The Use of COLD-PCR and High-Resolution Melting Analysis Improves the Limit of Detection of KRAS and BRAF Mutations in Colorectal Cancer  Irene Mancini,
Molecular Diagnostic Profiling of Lung Cancer Specimens with a Semiconductor-Based Massive Parallel Sequencing Approach  Volker Endris, Roland Penzel,
Mutant Enrichment with 3′-Modified Oligonucleotides
Carol Beadling, Tanaya L. Neff, Michael C
Detection of Low-Level KRAS Mutations Using PNA-Mediated Asymmetric PCR Clamping and Melting Curve Analysis with Unlabeled Probes  Ji Eun Oh, Hee Sun.
A Quantitative Allele-Specific PCR Test for the BRAF V600E Mutation Using a Single Heterozygous Control Plasmid for Quantitation  Philippe Szankasi, N.
Suppression of Wild-Type Amplification by Selectivity Enhancing Agents in PCR Assays that Utilize SuperSelective Primers for the Detection of Rare Somatic.
Multiplex Preamplification of Serum DNA to Facilitate Reliable Detection of Extremely Rare Cancer Mutations in Circulating DNA by Digital PCR  Jennifer.
A Multiplex SNaPshot Assay as a Rapid Method for Detecting KRAS and BRAF Mutations in Advanced Colorectal Cancers  Sandrine Magnin, Erika Viel, Alice.
Pyrosequencing Is an Accurate and Reliable Method for the Analysis of Heteroplasmy of the A3243G Mutation in Patients with Mitochondrial Diabetes  Jing-bin.
Elena Castellanos-Rizaldos, Cloud Paweletz, Chen Song, Geoffrey R
Joanna Wang, Chetan Bettegowda  The Journal of Molecular Diagnostics 
Philippe Szankasi, Mohamed Jama, David W. Bahler 
Comparison of High-Resolution Melting Analysis, TaqMan Allelic Discrimination Assay, and Sanger Sequencing for Clopidogrel Efficacy Genotyping in Routine.
Comparison of Allelic Discrimination by dHPLC, HRM, and TaqMan in the Detection of BRAF Mutation V600E  Pablo Carbonell, María C. Turpin, Daniel Torres-Moreno,
A Pyrosequencing-Based Assay for the Rapid Detection of IDH1 Mutations in Clinical Samples  Prashanth Setty, Jennifer Hammes, Thomas Rothämel, Valentina.
Ken B. Waites, Li Xiao, Vanya Paralanov, Rose M. Viscardi, John I
Detection of BRAF p.V600E Mutations in Melanomas
Detection of KRAS and BRAF Mutations in Colorectal Carcinoma
Getting Things Backwards to Prevent Primer Dimers
Assessment of EGFR Mutation Status in Lung Adenocarcinoma by Immunohistochemistry Using Antibodies Specific to the Two Major Forms of Mutant EGFR  Marie.
Andrea Gaedigk, Amanda K. Riffel, J. Steven Leeder 
Christine L. Baker, Cecily P. Vaughn, Wade S. Samowitz 
Verification of Wild-Type EGFR Status in Non–Small Cell Lung Carcinomas Using a Mutant-Enriched PCR on Selected Cases  Yi-Lin Chen, Cheng-Chan Lu, Shu-Ching.
Hillary S. Sloane, James P. Landers, Kimberly A. Kelly 
Detection of Exon 12 Mutations in the JAK2 Gene
Driver Gene Mutations in Stools of Colorectal Carcinoma Patients Detected by Targeted Next-Generation Sequencing  Gemma Armengol, Virinder K. Sarhadi,
Markus Rechsteiner, Adriana von Teichman, Jan H
Genotyping of Frequent BRCA1/2 SNPs with Unlabeled Probes
Multiplex Amplification Coupled with COLD-PCR and High Resolution Melting Enables Identification of Low-Abundance Mutations in Cancer Samples with Low.
Keyur P. Patel, Bedia A. Barkoh, Zhao Chen, Deqin Ma, Neelima Reddy, L
KRAS Mutation The Journal of Molecular Diagnostics
BRAF Mutation Testing in Solid Tumors
Highly Sensitive Droplet Digital PCR Method for Detection of EGFR-Activating Mutations in Plasma Cell–Free DNA from Patients with Advanced Non–Small Cell.
Allele-Specific, Non-Extendable Primer Blocker PCR (AS-NEPB-PCR) for DNA Mutation Detection in Cancer  Haiying Wang, John Jiang, Bianca Mostert, Anieta.
Sanger Confirmation Is Required to Achieve Optimal Sensitivity and Specificity in Next- Generation Sequencing Panel Testing  Wenbo Mu, Hsiao-Mei Lu, Jefferey.
Larissa V. Furtado, Helmut C. Weigelin, Kojo S. J
Mutation Analysis of SLC26A4 for Pendred Syndrome and Nonsyndromic Hearing Loss by High-Resolution Melting  Neng Chen, Lisbeth Tranebjærg, Nanna Dahl.
Multiplexed High Resolution Melting Assay for Versatile Sample Tracking in a Diagnostic and Research Setting  Céline Helsmoortel, R. Frank Kooy, Geert.
Larissa V. Furtado, Helmut C. Weigelin, Kojo S. J
An Allele-Specific PCR System for Rapid Detection and Discrimination of the CYP2C19∗4A, ∗4B, and ∗17 Alleles  Stuart A. Scott, Qian Tan, Usman Baber,
Rapid and Reliable Detection of Glucose-6-Phosphate Dehydrogenase (G6PD) Gene Mutations in Han Chinese Using High-Resolution Melting Analysis  Jing-bin.
Application of COLD-PCR for Improved Detection of NF2 Mosaic Mutations
Detection of the JAK2 V617F Mutation by LightCycler PCR and Probe Dissociation Analysis  Marla Lay, Rajan Mariappan, Jason Gotlib, Lisa Dietz, Siby Sebastian,
A Novel Long-Range PCR Sequencing Method for Genetic Analysis of the Entire PKD1 Gene  Ying-Cai Tan, Alber Michaeel, Jon Blumenfeld, Stephanie Donahue,
Nested High-Resolution Melting Curve Analysis
Mutation Detection of Epidermal Growth Factor Receptor and KRAS Genes Using the Smart Amplification Process Version 2 from Formalin-Fixed, Paraffin-Embedded.
Simultaneous Amplification, Detection, and Analysis of Common Mutations in the Galactose-1-Phosphate Uridyl Transferase Gene  Mohamed Jama, Lesa Nelson,
Analytical Validation of a Personalized Medicine APOL1 Genotyping Assay for Nondiabetic Chronic Kidney Disease Risk Assessment  Jinglan Zhang, Anastasia.
Detection of the Activating JAK2 V617F Mutation in Paraffin-Embedded Trephine Bone Marrow Biopsies of Patients with Chronic Myeloproliferative Diseases 
Rapid and Sensitive Real-Time Polymerase Chain Reaction Method for Detection and Quantification of 3243A>G Mitochondrial Point Mutation  Rinki Singh,
Rapid Mutation Screening for HRPT2 and MEN1 Mutations Associated with Familial and Sporadic Primary Hyperparathyroidism  Viive M. Howell, John W. Cardinal,
Validation of High-Resolution DNA Melting Analysis for Mutation Scanning of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Gene  Marie-Pierre.
Amplification Refractory Mutation System, a Highly Sensitive and Simple Polymerase Chain Reaction Assay, for the Detection of JAK2 V617F Mutation in Chronic.
Danielle C. Smith, Alina Esterhuizen, Jacquie Greenberg 
A Rapid and Reliable Test for BRCA1 and BRCA2 Founder Mutation Analysis in Paraffin Tissue Using Pyrosequencing  Liying Zhang, Tomas Kirchhoff, Cindy.
A Platform for Rapid Detection of Multiple Oncogenic Mutations With Relevance to Targeted Therapy in Non–Small-Cell Lung Cancer  Zengliu Su, Dora Dias-Santagata,
Novel Method for PIK3CA Mutation Analysis
Rapid Polymerase Chain Reaction-Based Detection of Epidermal Growth Factor Receptor Gene Mutations in Lung Adenocarcinomas  Qiulu Pan, William Pao, Marc.
Improved Detection of KIT Exon 11 Duplications in Formalin-Fixed, Paraffin-Embedded Gastrointestinal Stromal Tumors  Jerzy Lasota, Bartosz Wasag, Sonja.
Evaluation of High-Resolution Melting Analysis as a Diagnostic Tool to Detect the BRAF V600E Mutation in Colorectal Tumors  Martin Pichler, Marija Balic,
Xiangfeng Cui, Helen Feiner, Honghua Li 
Detection of BRCA1 and BRCA2 Ashkenazi Jewish Founder Mutations in Formalin- Fixed Paraffin-Embedded Tissues Using Conventional PCR and Heteroduplex/Amplicon.
Nathan D. Montgomery, Sara R. Selitsky, Nirali M. Patel, D
Improved Detection of the KIT D816V Mutation in Patients with Systemic Mastocytosis Using a Quantitative and Highly Sensitive Real-Time qPCR Assay  Thomas.
Establishment of a Molecular Diagnostic System for Spinal Muscular Atrophy  Jian Zeng, Yanhong Lin, Aizhen Yan, Longfeng Ke, Zhongyong Zhu, Fenghua Lan 
Presentation transcript:

Multiplex Amplification Coupled with COLD-PCR and High Resolution Melting Enables Identification of Low-Abundance Mutations in Cancer Samples with Low DNA Content  Coren A. Milbury, Clark C. Chen, Harvey Mamon, Pingfang Liu, Sandro Santagata, G. Mike Makrigiorgos  The Journal of Molecular Diagnostics  Volume 13, Issue 2, Pages 220-232 (March 2011) DOI: 10.1016/j.jmoldx.2010.10.008 Copyright © 2011 American Society for Investigative Pathology and the Association for Molecular Pathology Terms and Conditions

Figure 1 A 185-bp amplicon of TP53 exon 7 was analyzed via HRM after conventional PCR (A) and COLD-PCR (C). Amplicons were subsequently sequenced (Sanger, sense strand). While a 5% mutant abundance of the HCC2157 cell line (C>T) is unreliable in the chromatogram of conventional PCR amplicons (B), a 3% mutant abundance is easily visible in the chromatogram of COLD-PCR (D). Wild-type (WT) sequences are presented for comparison. The Journal of Molecular Diagnostics 2011 13, 220-232DOI: (10.1016/j.jmoldx.2010.10.008) Copyright © 2011 American Society for Investigative Pathology and the Association for Molecular Pathology Terms and Conditions

Figure 2 In the exon 8 (128 bp) amplicon, a low-abundance mutation in a colorectal tumor sample (CT20) was detected after analyzing COLD-PCR amplicons with HRM (A); however, this mutation was not detected in conventional PCR amplicons. An additional three samples possessed mid- to high-abundance mutations detectable by HRM screening of both conventional and COLD-PCR amplicons. For the exon 8 (128 bp) amplicon, Sanger sequencing analysis (sense strand) of the multiplexed-PCR product for CT20 revealed a G>A mutation in the sequence chromatograms of COLD-PCR (B); however, this mutation was not detected in conventional PCR amplicons. The mutation was confirmed in subsequent analysis of the COLD-PCR-amplified genomic DNA (C); however, the mutation was not observed in either the conventional PCR amplicon or the matched normal sample (D). The Journal of Molecular Diagnostics 2011 13, 220-232DOI: (10.1016/j.jmoldx.2010.10.008) Copyright © 2011 American Society for Investigative Pathology and the Association for Molecular Pathology Terms and Conditions

Figure 3 In the exon 9 amplicon, a low abundance mutation in a colorectal tumor sample (CT20) was detected after analyzing COLD-PCR amplicons with HRM (A); however, this mutation was not detectable in conventional PCR amplicons. An additional six samples possessed mid- to high-abundance SNPs detectable by HRM screening of both conventional and COLD-PCR amplicons. For the exon 9 amplicon, Sanger sequencing analysis of the multiplexed-PCR product for CT20 revealed a C>T mutation in the sequence chromatograms of COLD-PCR (B, anti-sense strand sequencing presented); however, this mutation was not detectable in conventional PCR amplicons or the matched normal sample (D). The mutation was confirmed in subsequent analysis of the COLD-PCR amplified genomic DNA (C). The Journal of Molecular Diagnostics 2011 13, 220-232DOI: (10.1016/j.jmoldx.2010.10.008) Copyright © 2011 American Society for Investigative Pathology and the Association for Molecular Pathology Terms and Conditions

Figure 4 In the exon 5 (148bp) amplicon, several mid- to high- abundance mutations were detected in the tumor samples, including colorectal tumor sample CT20. Additionally, after analyzing COLD-PCR amplicons with HRM (A), a low-abundance mutation was detected in CT2; however, this mutation was not detectable in conventional PCR amplicons. A mid- to high-abundance mutation was detected in CT20 by HRM for both PCR amplicons of the exon 5 148bp amplicon (in addition to the previously discussed low-abundance mutations in exons 8 and 9). Sanger sequencing analysis (sense strand) of the multiplexed-PCR product (B) and genomic DNA (C) for CT20 revealed a heterozygous G>T mutation in conventional PCR amplicons; the T allele was enriched during COLD-PCR. The mutation was also detected in the COLD-PCR amplification of the matched normal tissue (D), suggesting that the putatively normal sample may contain tissue from the tumor margin. This G>T is unlikely to be artifact of COLD-PCR as it is not observed in the wild-type (genomic human male) amplicons (E). The Journal of Molecular Diagnostics 2011 13, 220-232DOI: (10.1016/j.jmoldx.2010.10.008) Copyright © 2011 American Society for Investigative Pathology and the Association for Molecular Pathology Terms and Conditions